James G. Kublin

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 63 papers. Top paper: “Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial”.

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Science(2022)10.1126/science.abm3425

N/A

17.7DataRank · unranked

1207 citations

David C. Montefiori, Adrian B. McDermott, Youyi Fong, David Benkeser, Weiping Deng +38 more

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

New England Journal of Medicine(2021)10.1056/nejmoa2031738

N/A

6.2DataRank · unranked

547 citations

Peter B. Gilbert, Michal Juraska, David C. Montefiori, Lynn Morris, Shelly Karuna +40 more

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

The Lancet HIV(2020)10.1016/s2352-3018(20)30229-0

N/A

2.7DataRank · unranked

91 citations

Daniel J Stieh, Michal Sarnecki, Stephen R. Walsh, Georgia D. Tomaras, James G. Kublin +36 more

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

Nature Microbiology(2022)10.1038/s41564-022-01262-1

N/A

2.6DataRank · unranked

93 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa

EClinicalMedicine(2020)10.1016/j.eclinm.2020.100313

N/A

2.3DataRank · unranked

75 citations

One Dintwe, Andrew Fioré-Gartland, Keren Middelkoop, Julia Hütter, Anthony Williams +16 more

PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection

PLoS Pathogens(2021)10.1371/journal.ppat.1009594

N/A

1.5DataRank · unranked

60 citations

Gregory A. Deye, B. Kim Lee Sim, Shirley Galbiati, Jessie K. Kennedy, Kristen W. Cohen +9 more

Safety, Pharmacokinetics, and Causal Prophylactic Efficacy of KAF156 in a Plasmodium falciparum Human Infection Study

Clinical Infectious Diseases(2020)10.1093/cid/ciaa952

N/A

1.4DataRank · unranked

29 citations

Sean C. Murphy, Janine Maenza, Annette M. Seilie, Jay Prakash Jain, David Berger +14 more

Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial

Science Translational Medicine(2023)10.1126/scitranslmed.ade9078

N/A

1.3DataRank · unranked

48 citations

David C. Montefiori, Adrian B. McDermott, Youyi Fong, Holly Janes, Weiping Deng +43 more

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial

The Lancet Infectious Diseases(2024)10.1016/s1473-3099(24)00358-x

N/A

1.3DataRank · unranked

40 citations

Kathryn Mngadi, Ludo Lavreys, Steven Nijs, Peter B. Gilbert, John Hural +60 more

Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein

Clinical Infectious Diseases(2020)10.1093/cid/ciz1239

N/A

1.2DataRank · unranked

35 citations

Craig Innes, Sarita Naidoo, Philipp Mann, Julia Hütter, Gita Ramjee +69 more

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

PLoS Medicine(2020)10.1371/journal.pmed.1003038

N/A

1.2DataRank · unranked

48 citations

Zoe Moodie, Kristen W. Cohen, Nicole Grunenberg, Linda‐Gail Bekker, Mary Allen +26 more

Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac260

N/A

1.1DataRank · unranked

50 citations

One Dintwe, Sheetal Sawant, Doug Grove, Yunda Huang, Holly Janes +43 more

Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study

PLoS Medicine(2021)10.1371/journal.pmed.1003868

N/A

1.1DataRank · unranked

25 citations

Shuying Sue Li, Shannon Grant, Stephen R. Walsh, Ian Frank, Martin Casapia-Morales +11 more

Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac445

N/A

0.872DataRank · unranked

36 citations

Dan H. Barouch, Christy Comeaux, Michal Sarnecki, Kathryn E. Stephenson, Stephen R. Walsh +43 more

Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial

Nature Communications(2024)10.1038/s41467-024-53727-y

N/A

0.644DataRank · unranked

21 citations

Ollivier Hyrien, Youyi Fong, David Benkeser, Sanne Roels, Daniel J Stieh +56 more

A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection

Science Translational Medicine(2022)10.1126/scitranslmed.abn9709

N/A

0.590DataRank · unranked

50 citations

Ashley M. Vaughan, James G. Kublin, Matthew Fishbauger, Annette M. Seilie, Kurtis P. Cruz +20 more

Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine

npj Vaccines(2023)10.1038/s41541-023-00630-0

N/A

0.557DataRank · unranked

40 citations

Youyi Fong, Holly Janes, Elizabeth J. Kelly, Ian Hirsch, Stephanie Sproule +37 more

Safety and immunogenicity of a polyvalent DNA–protein HIV vaccine with matched Env immunogens delivered as a prime–boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial

The Lancet HIV(2024)10.1016/s2352-3018(24)00036-5

N/A

0.530DataRank · unranked

10 citations

Shuying S. Li, Nicole Grunenberg, Edgar T. Overton, Samuel T. Robinson, Hua Zheng +20 more

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial

PLoS Medicine(2024)10.1371/journal.pmed.1004360

N/A

0.439DataRank · unranked

9 citations

Erica Andersen‐Nissen, Nicole Grunenberg, One Dintwe, Faatima Laher Omar, Jia Jin Kee +29 more

A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa

PLoS ONE(2020)10.1371/journal.pone.0231086

N/A

0.434DataRank · unranked

17 citations

Stefanie Hornschuh, Mamakiri Khunwane, Lerato M. Makhale, Kennedy Otwombe, Cecilia Morgan +9 more

Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial

Nature Communications(2024)10.1038/s41467-024-52348-9

N/A

0.428DataRank · unranked

9 citations

Youyi Fong, Jonathan Fintzi, Eric Chun‐Pu Chu, Holly Janes, Avi Kenny +37 more

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study

EBioMedicine(2024)10.1016/j.ebiom.2024.105320

N/A

0.425DataRank · unranked

16 citations

Janine van Duijn, One Dintwe, Jack Heptinstall, Randy I. Burnham, Sheetal Sawant +93 more

Risk of COVID-19 after natural infection or vaccination

EBioMedicine(2023)10.1016/j.ebiom.2023.104799

N/A

0.396DataRank · unranked

13 citations

Matthew B. Laurens, Ying Huang, Chenchen Yu, Thomas Martin, Carina A. Rodriguez +94 more

Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad434

N/A

0.395DataRank · unranked

7 citations

Fatima Laher, One Dintwe, Monde Muyoyeta, Allan C. deCamp, Zonglin He +27 more

Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns

medRxiv(2024)10.1101/2024.10.15.24315548

N/A

0.299DataRank · unranked

2 citations

Kennedy Otwombe, William O. Hahn, Shi‐Yu Chen, Deirdre Josipovic, Vuyelwa Baba +18 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

EClinicalMedicine(2025)10.1016/j.eclinm.2024.103054

N/A

0.269DataRank · unranked

5 citations

Asa Tapley, Aaron Hudson, Sufia Dadabhai, Bo Zhang, Nyaradzo Mgodi +93 more

A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials

Emerging Microbes & Infections(2025)10.1080/22221751.2025.2485317

N/A

0.260DataRank · unranked

4 citations

Shuying Sue Li, Elena Giorgi, LaTonya D. Williams, One Dintwe, Lindsay N. Carpp +34 more

Safety and implementation of phase I randomized GLA-SE–adjuvanted CH505TF gp120 HIV vaccine trial in newborns

Journal of Clinical Investigation(2025)10.1172/jci186927

N/A

0.208DataRank · unranked

3 citations

Kennedy Otwombe, William O. Hahn, Shi‐Yu Chen, Deirdre Josipovic, Vuyelwa Baba +18 more

Patterns and predictors of COVID-19 vaccination among young adults at 44 US sites: Secondary analysis of a randomized, controlled, open-label trial, March – December 2021

Vaccine(2024)10.1016/j.vaccine.2024.126237

N/A

0.165DataRank · unranked

2 citations

Nicole K. Kelly, Christina Ludema, Molly Rosenberg, Elizabeth R. Brown, Holly E. Janes +5 more

Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial

iScience(2025)10.1016/j.isci.2025.113660

N/A

0.104DataRank · unranked

1 citations

Youyi Fong, Lars van der Laan, Fei Heng, Ying Huang, Yiwen Lu +61 more

Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine

Clinical Infectious Diseases(2025)10.1093/cid/ciaf558

N/A

0.104DataRank · unranked

1 citations

Yunda Huang, Ying Huang, Wayne Woo, Alice McGarry, Germán Áñez +37 more

Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults

Vaccines(2020)10.3390/vaccines8040741

N/A

0DataRank · unranked

27 citations

Stephen C. De Rosa, Marnie Elizaga, Yiwen Lu, Xue Han, Yunda Huang +21 more

Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial

Viruses(2023)10.3390/v15102029

N/A

0DataRank · unranked

17 citations

Nima S. Hejazi, Bryan S. Blette, Lindsay N. Carpp, David Benkeser, David C. Montefiori +38 more

Molecular detection of pre-ribosomal RNAs of Mycobacterium bovis bacille Calmette-Guérin and Mycobacterium tuberculosis to enhance pre-clinical tuberculosis drug and vaccine development

Diagnostic Microbiology and Infectious Disease(2023)10.1016/j.diagmicrobio.2023.116106

N/A

0DataRank · unranked

2 citations

Sambasivan Venkatasubramanian, Holly Barrett, Kevin B. Urdahl, Kris M. Weigel, Gerard A. Cangelosi +10 more

Strain-level characterization of health-associated bacterial consortia that colonize the human gut during infancy

medRxiv(2023)10.1101/2023.12.16.23300077

N/A

0DataRank · unranked

0 citations

Koshlan Mayer-Blackwell, Andrew Fioré-Gartland, Andrew M. Johnson, Steven G. Self, Parveen Bhatti +6 more

A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated

UNC Libraries(2023)10.17615/wz35-3h79

N/A

0DataRank · unranked

0 citations

Michael P. Fay, Dean Follmann, Deborah Donnell, James G. Kublin, Myron S. Cohen +24 more

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

PLoS Medicine(2020)10.1371/journal.pmed.1003117

N/A

0DataRank · unranked

14 citations

Stephen R. Walsh, Fatima Laher, Lucas Maganga, Michael E. Herce, Sarita Naidoo +28 more

Adolescent BCG revaccination induces a phenotypic shift in CD4+ T cell responses to Mycobacterium tuberculosis

Nature Communications(2024)10.1038/s41467-024-49050-1

N/A

0DataRank · unranked

8 citations

Lamar M. Fleming, Valentin Voillet, John McNevin, Aaron Seese, Anneta Naidoo +9 more

Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial

PLoS ONE(2021)10.1371/journal.pone.0241708

N/A

0DataRank · unranked

10 citations

Kennedy Otwombe, Koleka Mlisana, Maphoshane Nchabeleng, Mary Allen, James G. Kublin +6 more

Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses

Viruses(2024)10.3390/v16091365

N/A

0DataRank · unranked

2 citations

S. Munir Alam, Erica Andersen‐Nissen, Lindsay N. Carpp, One Dintwe, Britta Flach +12 more

Probing Dermal Immunity to Mycobacteria through a Controlled Human Infection Model

ImmunoHorizons(2024)10.4049/immunohorizons.2400053

N/A

0DataRank · unranked

1 citations

Emma Bishop, Andrew Fioré-Gartland, Krystle K. Q. Yu, Ming Chang, Richard M. Jones +20 more

Species- and subspecies-level characterization of health-associated bacterial consortia that colonize the human gut during infancy

Gut Microbes(2024)10.1080/19490976.2024.2414975

N/A

0DataRank · unranked

3 citations

Koshlan Mayer-Blackwell, Andrew Fioré-Gartland, Andrew M. Johnson, Steven G. Self, Parveen Bhatti +6 more

Statistical design and analysis of controlled human malaria infection trials

Malaria Journal(2024)10.1186/s12936-024-04959-2

N/A

0DataRank · unranked

0 citations

Holly Janes, James G. Kublin, Xiaowen Tian

HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae558

N/A

0DataRank · unranked

0 citations

L. W. Preston Church, Colleen F. Kelley, Samuel T. Robinson, Yiwen Lu, Briana D. Furch +13 more

Distinct gastrointestinal microbial signatures predict parasite levels in controlled Plasmodium infections in both rhesus macaques and humans

Nature Communications(2025)10.1038/s41467-025-67241-2

N/A

0DataRank · unranked

2 citations

Courtney A. Broedlow, Kevin Hager, Ernesto Coronado, Solomon Wangari, Naoto Iwayama +10 more

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV

Nature Communications(2025)10.1038/s41467-025-63948-4

N/A

0DataRank · unranked

1 citations

Bo Zhang, Caroline Brackett, Peter Elyanu, Asa Tapley, Sufia Dadabhai +95 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

UNC Libraries(2025)10.17615/p4hj-9n46

N/A

0DataRank · unranked

0 citations

Jia Jin Kee, Mubiana Inambao, Essack Mitha, Dishiki Kalonji, William Brumskine +76 more

IgG and Fc Receptor Genetic Variation Associates With Functional Antibody Responses in a DNA and Protein Candidate HIV Vaccine Trial

JAIDS Journal of Acquired Immune Deficiency Syndromes(2025)10.1097/qai.0000000000003734

N/A

0DataRank · unranked

0 citations

Song Young Oh, Nigel Garrett, James G. Kublin, Cynthia L. Monaco, Spencer Watts +7 more

Plasmodium falciparum Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected Adults

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf398

N/A

0DataRank · unranked

0 citations

Millicent Achola, Jack Hutter, Grace Mboya, Walter Otieno, Jia Jin Kee +16 more

COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials

Clinical Infectious Diseases(2024)10.1093/cid/ciae192

N/A

0DataRank · unranked

6 citations

Jessica Tuan, Valeria D Cantos, Oladunni Adeyiga, Scott Mahoney, Ana M. Ortega‐Villa +25 more

High Asymptomatic Carriage With the Omicron Variant in South Africa

Clinical Infectious Diseases(2022)10.1093/cid/ciac237

N/A

0DataRank · unranked

81 citations

Asa Tapley, Jessica Andriesen, Ishen Seocharan, Leigh H. Fisher, Lisa Bunts +85 more

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk

PLoS Pathogens(2021)10.1371/journal.ppat.1009363

N/A

0DataRank · unranked

30 citations

Andrew Fioré-Gartland, Lamar M. Fleming, Lindsay N. Carpp, Anneta Naidoo, Michael S. Harper +13 more

Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment

PLoS ONE(2021)10.1371/journal.pone.0258858

N/A

0DataRank · unranked

108 citations

Gail Broder, Stephaun E. Wallace, Richa Chaturvedi, Nelson L. Michael, Sally Bock +8 more

Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

UNC Libraries(2020)10.17615/2f0r-b813

N/A

0DataRank · unranked

0 citations

Michael S. Seaman, David C. Montefiori, Kshitij Wagh, Glenda Gray, Feng Gao +33 more

Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel

The Lancet HIV(2022)10.1016/s2352-3018(22)00255-7

N/A

0DataRank · unranked

18 citations

Mark Hatherill, Vidya Mave, Glenda Gray, Sharon Nachman, Sarah W. Read +27 more

Rethinking detection of pre-existing and intervening Plasmodium infections in malaria clinical trials

Frontiers in Immunology(2022)10.3389/fimmu.2022.1003452

N/A

0DataRank · unranked

11 citations

Dianna Hergott, Annette M. Seilie, Weston Staubus, Chris Chavtur, Ming Chang +4 more

Multi-trial analysis of HIV-1 envelope gp41-reactive antibodies among global recipients of candidate HIV-1 vaccines

Frontiers in Immunology(2022)10.3389/fimmu.2022.983313

N/A

0DataRank · unranked

6 citations

Andrew M. Johnson, Nicole Potchen, Simon S. Minot, Jack Heptinstall, Kelly E. Seaton +6 more

Immune Correlates Analysis of the PREVENT-19 COVID-19 Vaccine Efficacy Clinical Trial

medRxiv(2022)10.1101/2022.06.22.22276362

N/A

0DataRank · unranked

15 citations

Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo +35 more

Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial

medRxiv(2022)10.1101/2022.04.06.22272763

N/A

0DataRank · unranked

12 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

Developing TB Vaccines for People with HIV: A Roadmap: Meeting Consensus Report

Research Square(2022)10.21203/rs.3.rs-1605760/v1

N/A

0DataRank · unranked

1 citations

Mark Hatherill, Vidya Mave, Judith S. Currier, Joseph J. Eron, Glenda Gray +31 more

Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

Nature Communications(2023)10.1038/s41467-022-35768-3

N/A

0DataRank · unranked

102 citations

Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo +35 more

Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials

medRxiv(2020)10.1101/2020.12.14.20248137

N/A

0DataRank · unranked

25 citations

Jonathan Fintzi, Michael P. Fay, Holly Janes, Lindsey R. Baden, Hana M. El Sahly +25 more

Sporozoite immunization: innovative translational science to support the fight against malaria

Expert Review of Vaccines(2023)10.1080/14760584.2023.2245890

N/A

0DataRank · unranked

47 citations

L. W. Preston Church, Tooba Murshedkar, Peter F. Billingsley, Eric R. James, Mei‐Chun Chen +41 more